ARTICLE | Clinical News
Onfi clobazam regulatory update
October 31, 2011 7:00 AM UTC
FDA approved an NDA from H. Lundbeck for Onfi clobazam as an adjunctive therapy for seizures associated with Lennox-Gastaut syndrome (LGS) in patients >=2 years. The pharma plans to launch Onfi in the...